Development of Risk-Based Guidelines for Pediatric Cancer Survivors: The Children's Oncology Group Long-Term Follow-Up Guidelines From the Children's Oncology Group Late Effects Committee and Nursing Discipline

Wendy Landier; Smita Bhatia; Debra A Eshelman; Katherine J Forte; Teresa Sweeney; Allison L Hester; Joan Darling; F. Daniel Armstrong; Julie Blatt; Louis S Constine; Carolyn R Freeman; Debra L Friedman; Daniel M Green; Neyssa Marina; Anna T Meadows; Joseph P Neglia; Kevin C Oeffinger; Leslie L Robison; Kathleen S Ruccione; Charles A Sklar; Melissa M Hudson

doi:10.1200/JCO.2004.11.032

Back

Development of Risk-Based Guidelines for Pediatric Cancer Survivors: The Children's Oncology Group Long-Term Follow-Up Guidelines From the Children's Oncology Group Late Effects Committee and Nursing Discipline

Journal article

Peer reviewed

Development of Risk-Based Guidelines for Pediatric Cancer Survivors: The Children's Oncology Group Long-Term Follow-Up Guidelines From the Children's Oncology Group Late Effects Committee and Nursing Discipline

Wendy Landier, Smita Bhatia, Debra A Eshelman, Katherine J Forte, Teresa Sweeney, Allison L Hester, Joan Darling, F. Daniel Armstrong, Julie Blatt, Louis S Constine, …

Journal of clinical oncology, Vol.22(24), pp.4979-4990

2004-12-15

DOI: https://doi.org/10.1200/JCO.2004.11.032

PMID: 15576413

Abstract

The Children’s Oncology Group Long-Term Follow-Up Guidelines for Survivors of Childhood, Adolescent, and Young Adult Cancers are risk-based, exposure-related clinical practice guidelines intended to promote earlier detection of and intervention for complications that may potentially arise as a result of treatment for pediatric malignancies. Developed through the collaborative efforts of the Children’s Oncology Group Late Effects Committee, Nursing Discipline, and Patient Advocacy Committee, these guidelines represent a statement of consensus from a multidisciplinary panel of experts in the late effects of pediatric cancer treatment. The guidelines are both evidence-based (utilizing established associations between therapeutic exposures and late effects to identify high-risk categories) and grounded in the collective clinical experience of experts (matching the magnitude of risk with the intensity of screening recommendations). They are intended for use beginning 2 or more years following the completion of cancer therapy; however, they are not intended to provide guidance for follow-up of the survivor’s primary disease. A complementary set of patient education materials (“Health Links”) was developed to enhance follow-up care and broaden the application of the guidelines. The information provided in these guidelines is important for health care providers in the fields of pediatrics, oncology, internal medicine, family practice, and gynecology, as well as subspecialists in many fields. Implementation of these guidelines is intended to increase awareness of potential late effects and to standardize and enhance follow-up care provided to survivors of pediatric cancer throughout the lifespan. The Guidelines, and related Health Links, can be downloaded in their entirety at www.survivorshipguidelines.org .

Metrics

520 Record Views

531 Times Cited - Web of Science

See more details

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types: Domestic collaboration; International collaboration
Citation topics: 1 Clinical & Life Sciences; 1.112 Palliative Care; 1.112.1459 Childhood Cancer
Web Of Science research areas: Oncology
ESI research areas: Clinical Medicine

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

Source: InCites

Details

Title: Development of Risk-Based Guidelines for Pediatric Cancer Survivors: The Children's Oncology Group Long-Term Follow-Up Guidelines From the Children's Oncology Group Late Effects Committee and Nursing Discipline
Creators: Wendy Landier - From the Division of Pediatrics, City of Hope Comprehensive Cancer Center, Duarte; Department of Pediatric Hematology-Oncology, Stanford University Medical Center, Stanford; Division of Hematology-Oncology, Department of Pediatrics, USC Keck School of Medicine and Children's Hospital Los Angeles, CA; Center for Cancer and Blood Disorders, Children's Medical Center; Department of Family Practice and Community Medicine, University of Texas Southwestern Medical School, Dallas, TX; Division of Pediatric
Smita Bhatia - From the Division of Pediatrics, City of Hope Comprehensive Cancer Center, Duarte; Department of Pediatric Hematology-Oncology, Stanford University Medical Center, Stanford; Division of Hematology-Oncology, Department of Pediatrics, USC Keck School of Medicine and Children's Hospital Los Angeles, CA; Center for Cancer and Blood Disorders, Children's Medical Center; Department of Family Practice and Community Medicine, University of Texas Southwestern Medical School, Dallas, TX; Division of Pediatric
Debra A Eshelman - From the Division of Pediatrics, City of Hope Comprehensive Cancer Center, Duarte; Department of Pediatric Hematology-Oncology, Stanford University Medical Center, Stanford; Division of Hematology-Oncology, Department of Pediatrics, USC Keck School of Medicine and Children's Hospital Los Angeles, CA; Center for Cancer and Blood Disorders, Children's Medical Center; Department of Family Practice and Community Medicine, University of Texas Southwestern Medical School, Dallas, TX; Division of Pediatric
Katherine J Forte - From the Division of Pediatrics, City of Hope Comprehensive Cancer Center, Duarte; Department of Pediatric Hematology-Oncology, Stanford University Medical Center, Stanford; Division of Hematology-Oncology, Department of Pediatrics, USC Keck School of Medicine and Children's Hospital Los Angeles, CA; Center for Cancer and Blood Disorders, Children's Medical Center; Department of Family Practice and Community Medicine, University of Texas Southwestern Medical School, Dallas, TX; Division of Pediatric
Teresa Sweeney - From the Division of Pediatrics, City of Hope Comprehensive Cancer Center, Duarte; Department of Pediatric Hematology-Oncology, Stanford University Medical Center, Stanford; Division of Hematology-Oncology, Department of Pediatrics, USC Keck School of Medicine and Children's Hospital Los Angeles, CA; Center for Cancer and Blood Disorders, Children's Medical Center; Department of Family Practice and Community Medicine, University of Texas Southwestern Medical School, Dallas, TX; Division of Pediatric
Allison L Hester - From the Division of Pediatrics, City of Hope Comprehensive Cancer Center, Duarte; Department of Pediatric Hematology-Oncology, Stanford University Medical Center, Stanford; Division of Hematology-Oncology, Department of Pediatrics, USC Keck School of Medicine and Children's Hospital Los Angeles, CA; Center for Cancer and Blood Disorders, Children's Medical Center; Department of Family Practice and Community Medicine, University of Texas Southwestern Medical School, Dallas, TX; Division of Pediatric
Joan Darling - From the Division of Pediatrics, City of Hope Comprehensive Cancer Center, Duarte; Department of Pediatric Hematology-Oncology, Stanford University Medical Center, Stanford; Division of Hematology-Oncology, Department of Pediatrics, USC Keck School of Medicine and Children's Hospital Los Angeles, CA; Center for Cancer and Blood Disorders, Children's Medical Center; Department of Family Practice and Community Medicine, University of Texas Southwestern Medical School, Dallas, TX; Division of Pediatric
F. Daniel Armstrong - From the Division of Pediatrics, City of Hope Comprehensive Cancer Center, Duarte; Department of Pediatric Hematology-Oncology, Stanford University Medical Center, Stanford; Division of Hematology-Oncology, Department of Pediatrics, USC Keck School of Medicine and Children's Hospital Los Angeles, CA; Center for Cancer and Blood Disorders, Children's Medical Center; Department of Family Practice and Community Medicine, University of Texas Southwestern Medical School, Dallas, TX; Division of Pediatric
Julie Blatt - From the Division of Pediatrics, City of Hope Comprehensive Cancer Center, Duarte; Department of Pediatric Hematology-Oncology, Stanford University Medical Center, Stanford; Division of Hematology-Oncology, Department of Pediatrics, USC Keck School of Medicine and Children's Hospital Los Angeles, CA; Center for Cancer and Blood Disorders, Children's Medical Center; Department of Family Practice and Community Medicine, University of Texas Southwestern Medical School, Dallas, TX; Division of Pediatric
Louis S Constine - From the Division of Pediatrics, City of Hope Comprehensive Cancer Center, Duarte; Department of Pediatric Hematology-Oncology, Stanford University Medical Center, Stanford; Division of Hematology-Oncology, Department of Pediatrics, USC Keck School of Medicine and Children's Hospital Los Angeles, CA; Center for Cancer and Blood Disorders, Children's Medical Center; Department of Family Practice and Community Medicine, University of Texas Southwestern Medical School, Dallas, TX; Division of Pediatric
Carolyn R Freeman - From the Division of Pediatrics, City of Hope Comprehensive Cancer Center, Duarte; Department of Pediatric Hematology-Oncology, Stanford University Medical Center, Stanford; Division of Hematology-Oncology, Department of Pediatrics, USC Keck School of Medicine and Children's Hospital Los Angeles, CA; Center for Cancer and Blood Disorders, Children's Medical Center; Department of Family Practice and Community Medicine, University of Texas Southwestern Medical School, Dallas, TX; Division of Pediatric
Debra L Friedman - From the Division of Pediatrics, City of Hope Comprehensive Cancer Center, Duarte; Department of Pediatric Hematology-Oncology, Stanford University Medical Center, Stanford; Division of Hematology-Oncology, Department of Pediatrics, USC Keck School of Medicine and Children's Hospital Los Angeles, CA; Center for Cancer and Blood Disorders, Children's Medical Center; Department of Family Practice and Community Medicine, University of Texas Southwestern Medical School, Dallas, TX; Division of Pediatric
Daniel M Green - From the Division of Pediatrics, City of Hope Comprehensive Cancer Center, Duarte; Department of Pediatric Hematology-Oncology, Stanford University Medical Center, Stanford; Division of Hematology-Oncology, Department of Pediatrics, USC Keck School of Medicine and Children's Hospital Los Angeles, CA; Center for Cancer and Blood Disorders, Children's Medical Center; Department of Family Practice and Community Medicine, University of Texas Southwestern Medical School, Dallas, TX; Division of Pediatric
Neyssa Marina - From the Division of Pediatrics, City of Hope Comprehensive Cancer Center, Duarte; Department of Pediatric Hematology-Oncology, Stanford University Medical Center, Stanford; Division of Hematology-Oncology, Department of Pediatrics, USC Keck School of Medicine and Children's Hospital Los Angeles, CA; Center for Cancer and Blood Disorders, Children's Medical Center; Department of Family Practice and Community Medicine, University of Texas Southwestern Medical School, Dallas, TX; Division of Pediatric
Anna T Meadows - From the Division of Pediatrics, City of Hope Comprehensive Cancer Center, Duarte; Department of Pediatric Hematology-Oncology, Stanford University Medical Center, Stanford; Division of Hematology-Oncology, Department of Pediatrics, USC Keck School of Medicine and Children's Hospital Los Angeles, CA; Center for Cancer and Blood Disorders, Children's Medical Center; Department of Family Practice and Community Medicine, University of Texas Southwestern Medical School, Dallas, TX; Division of Pediatric
Joseph P Neglia - From the Division of Pediatrics, City of Hope Comprehensive Cancer Center, Duarte; Department of Pediatric Hematology-Oncology, Stanford University Medical Center, Stanford; Division of Hematology-Oncology, Department of Pediatrics, USC Keck School of Medicine and Children's Hospital Los Angeles, CA; Center for Cancer and Blood Disorders, Children's Medical Center; Department of Family Practice and Community Medicine, University of Texas Southwestern Medical School, Dallas, TX; Division of Pediatric
Kevin C Oeffinger - From the Division of Pediatrics, City of Hope Comprehensive Cancer Center, Duarte; Department of Pediatric Hematology-Oncology, Stanford University Medical Center, Stanford; Division of Hematology-Oncology, Department of Pediatrics, USC Keck School of Medicine and Children's Hospital Los Angeles, CA; Center for Cancer and Blood Disorders, Children's Medical Center; Department of Family Practice and Community Medicine, University of Texas Southwestern Medical School, Dallas, TX; Division of Pediatric
Leslie L Robison - From the Division of Pediatrics, City of Hope Comprehensive Cancer Center, Duarte; Department of Pediatric Hematology-Oncology, Stanford University Medical Center, Stanford; Division of Hematology-Oncology, Department of Pediatrics, USC Keck School of Medicine and Children's Hospital Los Angeles, CA; Center for Cancer and Blood Disorders, Children's Medical Center; Department of Family Practice and Community Medicine, University of Texas Southwestern Medical School, Dallas, TX; Division of Pediatric
Kathleen S Ruccione - From the Division of Pediatrics, City of Hope Comprehensive Cancer Center, Duarte; Department of Pediatric Hematology-Oncology, Stanford University Medical Center, Stanford; Division of Hematology-Oncology, Department of Pediatrics, USC Keck School of Medicine and Children's Hospital Los Angeles, CA; Center for Cancer and Blood Disorders, Children's Medical Center; Department of Family Practice and Community Medicine, University of Texas Southwestern Medical School, Dallas, TX; Division of Pediatric
Charles A Sklar - From the Division of Pediatrics, City of Hope Comprehensive Cancer Center, Duarte; Department of Pediatric Hematology-Oncology, Stanford University Medical Center, Stanford; Division of Hematology-Oncology, Department of Pediatrics, USC Keck School of Medicine and Children's Hospital Los Angeles, CA; Center for Cancer and Blood Disorders, Children's Medical Center; Department of Family Practice and Community Medicine, University of Texas Southwestern Medical School, Dallas, TX; Division of Pediatric
Melissa M Hudson - From the Division of Pediatrics, City of Hope Comprehensive Cancer Center, Duarte; Department of Pediatric Hematology-Oncology, Stanford University Medical Center, Stanford; Division of Hematology-Oncology, Department of Pediatrics, USC Keck School of Medicine and Children's Hospital Los Angeles, CA; Center for Cancer and Blood Disorders, Children's Medical Center; Department of Family Practice and Community Medicine, University of Texas Southwestern Medical School, Dallas, TX; Division of Pediatric
Publication Details: Journal of clinical oncology, Vol.22(24), pp.4979-4990
Academic Unit: Leadership Department; Miller School of Medicine; UMMG Dept of Pediatrics - Mailman Center for Child Development
Language: English
Resource Type: Journal article
PMID: 15576413
Record Identifier: 991031613155702976